Your browser doesn't support javascript.
loading
Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
Shen, Zhengnan; Ratia, Kiira; Krider, Isabella; Ackerman-Berrier, Martha; Penton, Christopher; Musku, Soumya Reddy; Gordon-Blake, Jesse M; Laham, Megan S; Christie, Nicholas; Ma, Nina; Fu, Jiqiang; Xiong, Rui; Courey, Jenna M; Velma, Ganga Reddy; Thatcher, Gregory R J.
Affiliation
  • Shen Z; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Ratia K; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Krider I; Research Resources Center, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Ackerman-Berrier M; Department of Chemistry & Biochemistry, Colleges of Science and Medicine, University of Arizona, Tucson, Arizona 85721, United States.
  • Penton C; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Musku SR; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Gordon-Blake JM; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Laham MS; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • Christie N; Department of Chemistry & Biochemistry, Colleges of Science and Medicine, University of Arizona, Tucson, Arizona 85721, United States.
  • Ma N; Department of Chemistry & Biochemistry, Colleges of Science and Medicine, University of Arizona, Tucson, Arizona 85721, United States.
  • Fu J; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Xiong R; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Courey JM; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Velma GR; Department of Chemistry & Biochemistry, Colleges of Science and Medicine, University of Arizona, Tucson, Arizona 85721, United States.
  • Thatcher GRJ; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
J Med Chem ; 66(24): 16704-16727, 2023 12 28.
Article in En | MEDLINE | ID: mdl-38096366
ABSTRACT
Depletion of nicotinamide adenine dinucleotide (NAD+) is associated with aging and disease, spurring the study of dietary supplements to replenish NAD+. The catabolism of NAD+ to nicotinamide (NAM) requires the salvage of NAM to replenish cellular NAD+, which relies on the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). Pharmacological activation of NAMPT provides an alternative to dietary supplements. Screening for activators of NAMPT identified small molecule NAMPT positive allosteric modulators (N-PAMs). N-PAMs bind to the rear channel of NAMPT increasing enzyme activity and alleviating feedback inhibition by NAM and NAD+. Synthesis of over 70 N-PAMs provided an excellent correlation between rear channel binding affinity and potency for enzyme activation, confirming the mechanism of allosteric activation via binding to the rear channel. The mechanism accounts for higher binding affinity leading to loss of efficacy. Enzyme activation translated directly to elevation of NAD+ measured in cells. Optimization led to an orally bioavailable N-PAM.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Nicotinamide Phosphoribosyltransferase / NAD Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Nicotinamide Phosphoribosyltransferase / NAD Language: En Year: 2023 Type: Article